Justice Clarence Thomas’s opinion for the Court ran only to eighteen pages, but those were densely packed with virtually impenetrable references (for the lay person) to such things as nucleotides, covalent bonds, introns, exons and pseudogenes. Many readers no doubt will share the view of Justice Antonin Scalia, in a short, separate opinion refusing to join in a section “going into the fine details of molecular biology,” of which he said he had neither knowledge or belief. Scalia said he did understand enough to accept that naturally isolated genes are different from synthetic ones, and that makes a difference in patent law.
The scientific and legal key to the Court’s denial of patent protection to isolated, natural forms of DNA were these sentences: “It is undisputed that Myriad did not create or alter any of the genetic information encoded in the BRCA1 and BRCA2 genes. The location and order of the nucleotides existed in nature before Myriad found them. Nor did Myriad create or alter the genetic structure of DNA.”
While that was not disputed, because the legal controversy focused rather on what Myriad claimed it did to locate and then isolate the forms of genetic DNA, those agreed-upon factors were enough to convince the Court that “Myriad did not create anything.” As Justice Thomas commented further: “To be sure, it found an important and useful gene, but separating that gene from its surrounding genetic material is not an act of invention. Groundbreaking, innovative, or even brilliant discovery does not by itself satisfy the [patent law] inquiry.”
The opinion conceded that Myriad probably did create something when it synthesized DNA, in a form that it called "complementary DNA," or cDNA. The challengers to Myriad on cDNA had contended that the sequence in that form had also been dictated by nature. That may be so, Thomas said in reaction, "but the lab technician unquestionably creates something new when cDNA is made."
The opinion said in a footnote, however, that the Court was not actually ruling that cDNA is specifically entitled to a composition patent, and noted that the federal government had raised other objections under patent law to that phenomenon.
The Thomas opinion went out of its way to make the ruling seem narrow, indeed — that is, virtually confined to the scientific specifics of what Myriad had done on natural genes and on synthetic versions. The opinion said that the Court was not ruling on any right to a patent on methods of manipulating the genes, and was not ruling on any applications of what Myriad had learned about the two cancer-suggesting genes, BRCA1 and BRCA2. Further, the Court had not passed upon the patentability of altering the genetic code in specific DNA forms.
Pages: 1 · 2
More Articles
- Attorney General Merrick B. Garland Statement on Supreme Court Ruling in Dobbs v. Jackson Women’s Health Organization
- Jo Freeman Reviews: Justice, Justice Thou Shalt Pursue: A Life’s Work Fighting for a More Perfect Union By Ruth Bader Ginsburg and Amanda Tyler
- Jo Freeman Writes: The Trumpsters are Coming; Donald Trump’s Devoted Followers Demand Four More Years
- Ruth Bader Ginsburg's Partial Remarks at the University of Buffalo, August 26, 2019: "If I am notorious, it is because I had the good fortune to be alive and a lawyer in the late 1960s"
- Women Firefighters Face High Exposure to Toxic ‘Forever Chemicals’ Known to Interfere with Immune and Endocrine Functions and Breast Development
- Kavanaugh Protests Continue: "Sexual Predators on the Court, Hell No, We Don’t Support" and "November Is Coming"
- Pew Trust: Voter Enthusiasm at Record High in Nationalized Midterm Environment
- Scientific American: How Reliable Are the Memories of Sexual Assault Victims? The Expert Testimony Excluded from the Kavanaugh Hearing
- A Most Unique Statement From FDA Commissioner Scott Gottlieb, M.D., On Efforts to Safeguard Women’s Health From Deceptive Health Claims and Significant Risks Related to Devices Marketed for Use in Medical Procedures for “Vaginal Rejuvenation"
- Elevating the Conversation: How a New Message Helped Win the Fight for Same-sex Marriage